Skip to main content

Table 1 Demographic and clinical characteristics of the cohort of patients with SSC enrolled in the study

From: NEMO score in nailfold videocapillaroscopy is a good tool to assess both steady state levels and overtime changes of disease activity in patients with systemic sclerosis: a comparison with the proposed composite indices for this disease status entity

Numbers of patients

98

Male/female ratio

8/90

Median age, years (range)

58 (21–84)

Median disease duration, years (range)

6 (0–26)

Median T1-T0 interval, months (range)

12 (4–56)

lcSSc/dcSSc

48/50

Autoantibodies

 ACA, n (%)

42 (42.8)

 Anti-Scl-70, n (%)

50 (51)

 Others, n (%)

6 (6.1)

NVC patterns

 Early, n (%)

16 (16.2)

 Active, n (%)

42 (42.8)

 Late, n (%)

40 (41)

Patients on prostanoid therapy, n (%)

32 (32.6)

  1. dcSSc diffuse cutaneous systemic sclerosis, lcSSc limited cutaneous systemic sclerosis, ACA anti-centromere antibody, ANA antinuclear antibodies, NVC nailfold videocapillaroscopy